Bridgewater Associates’s Alkermes ALKS Stock Holding History
Bought
Maintained
Sold
Other funds holding ALKS
BBA
DTC
Bridgewater Associates's ALKS Position: Q2 2026 in Review
Bridgewater Associates sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 83,806 shares — an estimated $2.96M sold.
Bridgewater Associates first reported a position in ALKS in Q2 2021 and held it in 14 quarters. The position peaked at $9.64M in Q4 2025. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.
- Bridgewater Associates reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
- Bridgewater Associates sold 83,806 Alkermes shares in Q2 2026, an estimated $2.96M.
- Bridgewater Associates first reported a position in Alkermes in Q2 2021 and held it in 14 quarters.
- Bridgewater Associates's Alkermes position peaked at $9.64M in Q4 2025.
- 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.